期刊
ONCOGENE
卷 35, 期 29, 页码 3854-3865出版社
SPRINGERNATURE
DOI: 10.1038/onc.2015.456
关键词
-
资金
- Regione Lombardia [ID14546A]
- Fondazione Berlucchi Onlus Grant
- FP7 ERC-StG [242965]
- Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG-12023]
- Koch Institute/DFCC Bridge Project Fund
- Ellison Foundation Boston
- Worldwide Cancer Research Association [12-0216]
- Grant for Oncology Innovation by Merck-Serono
- [R01 CA196703-01]
- European Research Council (ERC) [242965] Funding Source: European Research Council (ERC)
Most of the anaplastic large-cell lymphoma (ALCL) cases carry the t(2; 5; p23;q35) that produces the fusion protein NPM-ALK (nucleophosmin-anaplastic lymphoma kinase). NPM-ALK-deregulated kinase activity drives several pathways that support malignant transformation of lymphoma cells. We found that in ALK-rearranged ALCL cell lines, NPM-ALK was distributed in equal amounts between the cytoplasm and the nucleus. Only the cytoplasmic portion was catalytically active in both cell lines and primary ALCL, whereas the nuclear portion was inactive because of heterodimerization with NPM1. Thus, about 50% of the NPM-ALK is not active and sequestered as NPM-ALK/NPM1 heterodimers in the nucleus. Overexpression or relocalization of NPM-ALK to the cytoplasm by NPM genetic knockout or knockdown caused ERK1/2 (extracellular signal-regulated protein kinases 1 and 2) increased phosphorylation and cell death through the engagement of an ATM/Chk2- and gamma H2AX (phosphorylated H2A histone family member X)-mediated DNA-damage response. Remarkably, human NPM-ALK-amplified cell lines resistant to ALK tyrosine kinase inhibitors (TKIs) underwent apoptosis upon drug withdrawal as a consequence of ERK1/2 hyperactivation. Altogether, these findings indicate that an excess of NPM-ALK activation and signaling induces apoptosis via oncogenic stress responses. A 'drug holiday' where the ALK TKI treatment is suspended could represent a therapeutic option in cells that become resistant by NPM-ALK amplification.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据